Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × INDUSTRY × Infections × Clear all

Phase

Status

Completed 14 Withdrawn 2 Recruiting 2 Active not recruiting 2 Unknown 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 11 Hematologic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 5 Breast Neoplasms 5 Urinary Bladder Neoplasms 4 Leukemia, Myeloid, Acute 4 Colorectal Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Myasthenia Gravis 3 Multiple Myeloma 3 Lung Neoplasms 3 Kidney Neoplasms 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Lymphoma, B-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Heart Failure 2 Glioma 2 Glioblastoma 2 Esophageal Neoplasms 2 Diabetes Mellitus, Type 2 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07296263 2026-04-13

Contrast PMR

Hyperfine

Phase NA Enrolling by invitation

Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡